 COPENHAGEN, Denmark, Sept. 07, 2021 GLOBE NEWSWIRE -- Ascendis Pharma AS Nasdaq: ASND, a biopharmaceutical company that utilizes its innovative TransConTM technologies to potentially create new treatments that make a meaningful difference in patients lives, today announced that the company will participate in two upcoming investor conferences. Company executives will provide a business overview and update on the companys programs. 